Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q7Z3Z2
UPID:
RD3_HUMAN
Alternative names:
Retinal degeneration protein 3
Alternative UPACC:
Q7Z3Z2; A8K595
Background:
Protein RD3, also known as Retinal degeneration protein 3, is pivotal in regulating enzymes crucial for the nucleotide cycle in photoreceptors. It modulates the activity of retinal guanylyl cyclases GUCY2D and GUCY2F, essential for cGMP production, and plays a role in the transport of these enzymes to photoreceptor outer segments. Additionally, RD3 up-regulates GUK1 kinase activity, vital for GMP recycling.
Therapeutic significance:
Given its critical role in photoreceptor survival and its involvement in Leber congenital amaurosis 12, a severe retinal dystrophy, understanding the function of Protein RD3 could pave the way for innovative treatments for retinal diseases.